Your browser doesn't support javascript.
loading
Antibody Response from Whole-Cell Pertussis Vaccine Immunized Brazilian Children against Different Strains of Bordetella pertussis
Pereira, Alexandre; S. Pietro Pereira, Aparecida; Lopes Silva, Célio; de Melo Rocha, Gutemberg; Lebrun, Ivo; Sant'Anna, Osvaldo A; Tambourgi, Denise V.
Affiliation
  • Pereira, Alexandre; Instituto Butantan. São Paulo. BR
  • S. Pietro Pereira, Aparecida; InstitutoButantan. São Paulo. BR
  • Lopes Silva, Célio; Instituto Butantan. São Paulo. BR
  • de Melo Rocha, Gutemberg; Instituto Butantan. São Paulo. BR
  • Lebrun, Ivo; Instituto Butantan. São Paulo. BR
  • Sant'Anna, Osvaldo A; Instituto Butantan. São Paulo. BR
  • Tambourgi, Denise V; Instituto Butantan. São Paulo. BR
Article in English | Sec. Est. Saúde SP, SESSP-IBPROD, Sec. Est. Saúde SP, SESSP-IBACERVO | ID: biblio-1068137
Responsible library: BR78.1
Localization: BR78.1
ABSTRACT
Antibody Response from Whole-Cell Pertussis Vaccine Immunized Brazilian Children against Different Strains of Bordetella pertussisBordetella pertussis is a gram-negative bacillus that causes the highly contagious disease known as pertussis or whooping cough. Antibody response in children may vary depending on the vaccination schedule and the product used. In this study, we have analyzed the antibody response of cellular pertussis vaccinated children against B. pertussis strains and their virulence factors, such as pertussis toxin, pertactin, and filamentous hemagglutinin. After the completion of the immunization process, according to the Brazilian vaccination program, children serum samples were collected at different periods of time, and tested for the presence of specific antibodies and antigenic cross-reactivity. Results obtained show that children immunized with three doses of the Brazilian whole-cell pertussis vaccine present high levels of serum antibodies capable of recognizing the majority of the components present in vaccinal and non-vaccinal B. pertussis strains and their virulence factors for at least 2 years after the completion of the immunization procedure.
Subject(s)
Full text: Available Collection: National databases / Brazil Database: Sec. Est. Saúde SP / SESSP-IBACERVO / SESSP-IBPROD Main subject: Pertussis Vaccine Limits: Child / Humans Country/Region as subject: South America / Brazil Language: English Journal: The American Journal of Tropical Medicine and Hygiene Year: 2010 Document type: Article Institution/Affiliation country: Instituto Butantan/BR / InstitutoButantan/BR
Full text: Available Collection: National databases / Brazil Database: Sec. Est. Saúde SP / SESSP-IBACERVO / SESSP-IBPROD Main subject: Pertussis Vaccine Limits: Child / Humans Country/Region as subject: South America / Brazil Language: English Journal: The American Journal of Tropical Medicine and Hygiene Year: 2010 Document type: Article Institution/Affiliation country: Instituto Butantan/BR / InstitutoButantan/BR
...